These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 28657745

  • 1. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y, Basith S, Choi S.
    J Med Chem; 2018 Jan 11; 61(1):1-46. PubMed ID: 28657745
    [Abstract] [Full Text] [Related]

  • 2. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S, Sabio M.
    Biochem Pharmacol; 2009 Jul 01; 78(1):11-20. PubMed ID: 19447219
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM, Booe JM, Pioszak AA.
    Eur J Pharmacol; 2015 Sep 15; 763(Pt B):196-205. PubMed ID: 25981303
    [Abstract] [Full Text] [Related]

  • 5. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X, Topin J, Golebiowski J.
    Curr Pharm Des; 2017 Nov 16; 23(29):4390-4409. PubMed ID: 28699533
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S, Zhang J.
    J Med Chem; 2019 Jan 10; 62(1):24-45. PubMed ID: 29457894
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S.
    Methods Mol Biol; 2018 Jan 10; 1705():1-21. PubMed ID: 29188556
    [Abstract] [Full Text] [Related]

  • 12. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
    Christopher JA, Doré AS, Tehan BG.
    Curr Top Med Chem; 2017 Jan 10; 17(1):71-78. PubMed ID: 27448651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: A Structural Biology Perspective.
    Khorn PA, Luginina AP, Pospelov VA, Dashevsky DE, Khnykin AN, Moiseeva OV, Safronova NA, Belousov AS, Mishin AV, Borshchevsky VI.
    Biochemistry (Mosc); 2024 Apr 10; 89(4):747-764. PubMed ID: 38831510
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
    Li YY, Hou TJ, Goddard WA.
    Curr Med Chem; 2010 Apr 10; 17(12):1167-80. PubMed ID: 20158474
    [Abstract] [Full Text] [Related]

  • 20. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.
    Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S.
    Signal Transduct Target Ther; 2024 Apr 10; 9(1):88. PubMed ID: 38594257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.